American Society For Investigative Pathology Inc
- Assets
- $5.4m
- Revenue
- $1.9m
- Investments
- $0.0
- Employees
- 14
- Location
- Rockville, MD
- Founding
- 01/1968
- Data as of
- 12/2022
- EIN
- 94-6079945
Organization Overview
American Society For Investigative Pathology Inc is located in Rockville, MD. The organization was established in 1968. According to its NTEE Classification (H90) the organization is classified as: Medical Disciplines Research, under the broad grouping of Medical Research and related organizations. As of 12/2022, American Society For Investigative Pathology Inc employed 14 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. American Society For Investigative Pathology Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, American Society For Investigative Pathology Inc generated $1.9m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 5 years, the organization has seen revenues fall by an average of (4.9%) each year. All expenses for the organization totaled $2.7m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO PROMOTE THE DISCOVERY, ADVANCEMENT, AND DISSEMINATION OF KNOWLEDGE IN EXPERIMENTAL PATHOLOGY AND RELATED DISCIPLINES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
PUBLICATIONS AND MEMBER SERVICESTHE AMERICAN JOURNAL OF PATHOLOGY (AJP) IS THE LEADING GLOBAL FORUM FOR REPORTING QUALITY ORIGINAL RESEARCH ON CELLULAR AND MOLECULAR MECHANISMS OF DISEASE, AND IS THE OFFICIAL JOURNAL OF THE AMERICAN SOCIETY FOR INVESTIGATIVE PATHOLOGY (ASIP) AND IS PUBLISHED BY ELSEVIER, INC. THE JOURNAL PUBLISHES HIGH-QUALITY ORIGINAL RESEARCH REPORTS, REVIEWS, AND COMMENTARIES RELATED TO THE MOLECULAR AND CELLULAR BASIS OF DISEASE. THE EDITORS ACCEPT MANUSCRIPTS THAT ADVANCE BASIC, TRANSLATIONAL, AND CLINICAL KNOWLEDGE OF THE MECHANISMS OF PATHOGENESIS OR PROVIDE A FOUNDATION FOR FUTURE MECHANISTIC INQUIRIES. EXAMPLES OF SUCH FOUNDATIONAL INVESTIGATIONS INCLUDE DATA MINING, IDENTIFICATION OF BIOMARKERS, MOLECULAR PATHOLOGY, AND DISCOVERY RESEARCH. FOUNDATIONAL STUDIES THAT INCORPORATE DEEP LEARNING AND ARTIFICIAL INTELLIGENCE ARE ALSO WELCOME. HIGH PRIORITY IS GIVEN TO STUDIES OF HUMAN DISEASE AND RELEVANT EXPERIMENTAL MODELS USING MOLECULAR, CELLULAR, AND ORGANISMAL APPROACHES. THE AMERICAN JOURNAL OF PATHOLOGY IS THE MOST HIGHLY CITED JOURNAL IN THE FIELD OF PATHOLOGY RESEARCH.THE JOURNAL OF MOLECULAR DIAGNOSTICS (JMD) PUBLISHES HIGH-QUALITY ORIGINAL PAPERS ON SCIENTIFIC ADVANCES IN THE TRANSLATION AND VALIDATION OF MOLECULAR DISCOVERIES IN MEDICINE INTO THE CLINICAL DIAGNOSTIC SETTING, AND THE DESCRIPTION AND APPLICATION OF TECHNOLOGICAL ADVANCES IN THE FIELD OF MOLECULAR DIAGNOSTIC MEDICINE. ARTICLES REPORT NOVEL DISCOVERIES WITH DIRECT APPLICATION TO CLINICAL DIAGNOSTICS OR CLINICOPATHOLOGIC CORRELATIONS INCLUDING STUDIES IN ONCOLOGY, INFECTIOUS DISEASES, INHERITED DISEASES, PREDISPOSITION TO DISEASE, CLINICAL INFORMATICS, OR THE DESCRIPTION OF POLYMORPHISMS LINKED TO DISEASE STATES OR NORMAL VARIATIONS; THE APPLICATION OF DIAGNOSTIC METHODOLOGIES IN CLINICAL TRIALS; AND THE DEVELOPMENT OF NEW OR IMPROVED MOLECULAR METHODS FOR DIAGNOSIS OR MONITORING OF DISEASE OR DISEASE PREDISPOSITION. SPECIAL FEATURES INCLUDE TECHNICAL ADVANCES, A PEER-REVIEWED SECTION FEATURING NOVEL METHODS TO SOLVE DIAGNOSTIC DILEMMAS. REVIEWS, COMMENTARIES, AND SPECIAL ARTICLES PROVIDE FOCUS ON CONTROVERSIAL OR "HOT" RESEARCH TOPICS AND ISSUES.MEMBER SERVICESMEMBER SERVICES INCLUDE SCIENTIFIC INTEREST GROUPS, SCIENTIFIC MEETINGS, AND COMMITTEES.
EDUCATION AND CAREER DEVELOPMENTEDUCATION AND CAREER DEVELOPMENT FOR TRAINEES AND YOUNG INVESTIGATORS REPRESENTS A HIGH PRIORITY FOR THE SOCIETY. TO FACILITATE EDUCATIONAL AND CAREER DEVELOPMENT ACTIVITIES, THE ASIP HAS TWO STANDING COMMITTEES: THE EDUCATION COMMITTEE AND THE COMMITTEE FOR CAREER DEVELOPMENT. IN ADDITION, THE COMMITTEE FOR EQUAL REPRESENTATION AND OPPORTUNITY PROVIDES OVERSIGHT FOR THE SOCIETY'S DIVERSITY AND INCLUSION OBJECTIVES. TOGETHER, THESE GROUPS DEVELOP INITIATIVES AND PROGRAMS TO ACHIEVE THE GOAL OF PROVIDING TRAINEES, YOUNG INVESTIGATORS, AND OTHERS WITH SPECIFIC OPPORTUNITIES TO EXPAND THEIR KNOWLEDGE IN SPECIFIC AREAS OF BASIC, CLINICAL, AND TRANSLATIONAL PATHOBIOLOGY RESEARCH.FURTHER, WE PROVIDE OPPORTUNITIES FOR TRAINEES, YOUNG INVESTIGATORS, AND OTHERS TO ADVANCE THEIR CAREERS THROUGH MENTORING.
ADVOCACY ADVOCACY ACTIVITIES ARE ACHIEVED BY THE ASIP'S RESEARCH AND SCIENCE POLICY COMMITTEE. AREAS OF INTEREST INCLUDE ADVOCATING ON BEHALF OF FUNDING FOR RESEARCH INTO HUMAN DISEASES, HUMAN SUBJECTS PROTECTIONS IN RESEARCH, ETHICAL USE OF ANIMALS IN RESEARCH, TRANSLATIONAL RESEARCH, FUNDING FOR GRADUATE AND MEDICAL EDUCATION, PATHOLOGY WORKFORCE PIPELINE (INCLUDING CLINICAL PATHOLOGISTS AND BASIC SCIENCE RESEARCHERS), ADMINISTRATIVE BURDEN OF REGULATIONS, HEALTH INFORMATION TECHNOLOGY, GENE PATENT LAW, HIPPA POLICY AND IMPACT ON RESEARCH, AND ISSUES RELATED TO BIOREPOSITORY AND BIOSECURITY REGULATION.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
William B Coleman PHD Executive Officer | Officer | 50.25 | $282,122 |
Lisa Mcfadden Dir Of Scient. Mtgs, Membership, & Ed. | Officer | 40 | $150,923 |
Emily H Essex Director Of Scientific Publications | 40 | $118,625 | |
Chhavi Chauhan Director Of Scientific Outreach, Phd | 40 | $103,400 | |
William A Muller MD PHD President | OfficerTrustee | 4 | $0 |
Robinna Lorenz MD PHD President-Elect | OfficerTrustee | 4 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $19,019 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $19,019 |
| Total Program Service Revenue | $1,073,843 |
| Investment income | $203,162 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $588,443 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $22,163 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $1,908,277 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $12,250 |
| Grants and other assistance to domestic individuals. | $154,500 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $515,584 |
| Compensation of current officers, directors, key employees. | $188,560 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $759,999 |
| Pension plan accruals and contributions | $74,225 |
| Other employee benefits | $87,589 |
| Payroll taxes | $76,151 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $8,648 |
| Fees for services: Accounting | $126,559 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $37,333 |
| Fees for services: Other | $191,692 |
| Advertising and promotion | $15,020 |
| Office expenses | $77,630 |
| Information technology | $38,532 |
| Royalties | $0 |
| Occupancy | $177,057 |
| Travel | $83,548 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $156,277 |
| Interest | $14,664 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $45,373 |
| Insurance | $13,018 |
| All other expenses | $0 |
| Total functional expenses | $2,740,953 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $257,582 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $135,403 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $41,897 |
| Net Land, buildings, and equipment | $254,265 |
| Investments—publicly traded securities | $4,021,800 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $711,539 |
| Total assets | $5,422,486 |
| Accounts payable and accrued expenses | $324,280 |
| Grants payable | $0 |
| Deferred revenue | $204,535 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $814,181 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $1,144,374 |
| Total liabilities | $2,487,370 |
| Net assets without donor restrictions | $2,585,528 |
| Net assets with donor restrictions | $349,588 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $5,422,486 |
Grants Awarded
Over the last fiscal year, American Society For Investigative Pathology Inc has awarded $15,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
NORTH AMERICAN VASCULAR BIOLOGY ORGANIZATION PURPOSE: GENERAL SUPPORT | $10,000 |
INTERNATIONAL COUNCIL FOR PATHOLOGY INFORMATION INC PURPOSE: GENERAL SUPPORT | $5,000 |